Search research articles
Contact Us
Filters
Showing results (71-80 of 91) with videos related to
Page
of 10
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 5, 2018
Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer's disease dementia
Mark Belger, Josep Maria Haro, Catherine Reed, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 8, 2015
Determinants of societal costs in Alzheimer's disease: GERAS study baseline results
Richard Dodel, Mark Belger, Catherine Reed, et al.
Journal of Comparative Effectiveness Research
|
September 1, 2017
Practical implications of using real-world evidence (RWE) in comparative effectiveness research: learnings from IMI-GetReal
Amr Makady, Heather Stegenga, Antonio Ciaglia, et al.
The West Indian Medical Journal
|
February 23, 2016
Newborn Screening for Sickle Cell Disease: Jamaican Experience
K Mason, F Gibson, R Gardner, et al.
Anticancer Research
|
March 16, 2004
Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC)
K Link, K Happich, I Schirner, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
November 12, 2021
Final results of the southwest German pilot study on cystic fibrosis newborn screening - Evaluation of an IRT/PAP protocol with IRT-dependent safety net
Olaf Sommerburg, Mirjam Stahl, Susanne Hämmerling, et al.
Annals of Intensive Care
|
November 9, 2023
Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study
Antonia Greimel, Katharina Habler, Caroline Gräfe, et al.
Journal of Alzheimer'S Disease : JAD
|
May 1, 2013
The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings
Anders Wimo, Catherine C Reed, Richard Dodel, et al.
BMC Medical Research Methodology
|
July 20, 2016
How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study
Mark Belger, Josep Maria Haro, Catherine Reed, et al.
Annals of Hematology
|
December 15, 2015
Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening
Joachim B Kunz, Saida Awad, Margit Happich, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 91) with videos related to
Sort By:
Page
of 10
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 5, 2018
Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer's disease dementia
Mark Belger, Josep Maria Haro, Catherine Reed, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 8, 2015
Determinants of societal costs in Alzheimer's disease: GERAS study baseline results
Richard Dodel, Mark Belger, Catherine Reed, et al.
Journal of Comparative Effectiveness Research
|
September 1, 2017
Practical implications of using real-world evidence (RWE) in comparative effectiveness research: learnings from IMI-GetReal
Amr Makady, Heather Stegenga, Antonio Ciaglia, et al.
The West Indian Medical Journal
|
February 23, 2016
Newborn Screening for Sickle Cell Disease: Jamaican Experience
K Mason, F Gibson, R Gardner, et al.
Anticancer Research
|
March 16, 2004
Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC)
K Link, K Happich, I Schirner, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
November 12, 2021
Final results of the southwest German pilot study on cystic fibrosis newborn screening - Evaluation of an IRT/PAP protocol with IRT-dependent safety net
Olaf Sommerburg, Mirjam Stahl, Susanne Hämmerling, et al.
Annals of Intensive Care
|
November 9, 2023
Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study
Antonia Greimel, Katharina Habler, Caroline Gräfe, et al.
Journal of Alzheimer'S Disease : JAD
|
May 1, 2013
The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings
Anders Wimo, Catherine C Reed, Richard Dodel, et al.
BMC Medical Research Methodology
|
July 20, 2016
How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study
Mark Belger, Josep Maria Haro, Catherine Reed, et al.
Annals of Hematology
|
December 15, 2015
Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening
Joachim B Kunz, Saida Awad, Margit Happich, et al.
Page
of 10